Global Leading Market Research Publisher QYResearch announces the release of its latest report “High-Shear Granulation Mixing Equipment – Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032″. Based on current situation and impact historical analysis (2021-2025) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global High-Shear Granulation Mixing Equipment market, including market size, share, demand, industry development status, and forecasts for the next few years.
The global market for High-Shear Granulation Mixing Equipment was estimated to be worth US372millionin2025andisprojectedtoreachUS372millionin2025andisprojectedtoreachUS570 million by 2032, growing at a CAGR of 6.4% from 2026 to 2032. For pharmaceutical production managers, food processing engineers, and chemical plant operators, the core business imperative lies in selecting high-shear granulation mixing equipment that addresses the critical need for blending powders, liquids, and other ingredients into uniform mixtures while simultaneously forming granules (wet granulation) with controlled particle size distribution (PSD), improved flow properties (angle of repose), and enhanced compactness (tablet compressibility) for downstream processes (tableting, capsule filling, packaging). High-shear granulation mixing equipment operates by creating high-speed shear forces via rotating impeller (top-driven or bottom-driven) and chopper (high-speed rotary blade) to break up powder agglomerates, promote binding of particles into larger, more uniform granules (1-2mm). Process: dry mixing (powders, excipients), granulation liquid addition (water, binder solution, solvent), wet massing (agglomerate formation), wet screening, drying (fluid bed dryer), milling, final blending. Key applications: pharmaceutical industry (oral solid dosage forms (OSD) – tablets, capsules, granules for sachets), food industry (instant beverage granules, seasoning blends, soup mixes), chemical industry (detergent powders, fertilizer granules, catalyst supports), personal care products (cosmetic powders, toothpaste granules), and others (nutraceuticals, agrochemicals). Equipment capacity ranges from below 150L (R&D, pilot plant), 150L-600L (production scale), to above 600L (high-volume manufacturing). Prices vary from tens of thousands to hundreds of thousands of dollars.
【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/releases/6098073/high-shear-granulation-mixing-equipment
The High-Shear Granulation Mixing Equipment market is segmented as below:
GEA Group
Syntegon
ACG
Glatt Group
L.B. Bohle
IMA Group
Hosokawa Micron
Yenchen Machinery
DIOSNA Dierks & Söhne
Freund
Romaco
Fluid Air
PerMix
Shree Bhagwati Machtech
Cronimo
Gansons
Chamunda Pharma Machinery
Prism Pharma Machinery
Falcon Machineries
Anchor Mark
Tofflon
Segment by Type
Below 150L
150L-600L
Above 600L
Segment by Application
Pharmaceutical Industry
Food Industry
Chemical Industry
Personal Care Products
Others
1. Market Drivers: Pharmaceutical OSD Growth, Generic Drug Production, and Nutraceuticals
Several powerful forces are driving the high-shear granulation mixing equipment market:
Pharmaceutical oral solid dosage (OSD) market expansion – Tablets and capsules dominate drug delivery (70% of pharma formulations). New drug launches (NDAs, ANDAs) require granulation equipment. Generic drug manufacturing (India, China) increasing. GEA, Syntegon, Glatt, IMA, ACG, L.B. Bohle, Tofflon (China) equipment suppliers.
Generic drug and contract manufacturing (CMO) growth – CMOs require flexible, multi-product high-shear granulators (changeover cleaning validation). R&D batches (below 150L) up to commercial (600L+). India CMO growth.
Nutraceutical and supplement tablet production – Vitamins, minerals, herbal supplements (tablet, capsule, sachet). Food grade high-shear granulators. Personal care.
Recent market data (December 2025): According to Global Info Research analysis, 150L-600L capacity dominates with approximately 50% revenue share (production scale, most common for commercial manufacturing). Below 150L (R&D, pilot, small batch) 30% share. Above 600L (high-volume, continuous manufacturing) 20% share. Pharmaceutical industry largest application (65% share). Food industry 20% share. Chemical industry 10% share. Personal care 5% share. Asia-Pacific (China, India) largest market (45% share) manufacturing hub. Europe (Germany, Italy (IMA), Switzerland) 30% share. North America 20% share.
2. Equipment Types and Capacity Specifications
| Capacity | Batch Size (kg) | Typical Application | Impeller Speed (rpm) | Chopper Speed (rpm) | Price Range | Share |
|---|---|---|---|---|---|---|
| Below 150L | 10-100 kg | R&D, pilot, small batch, CMO (Contract Manufacturing Organizations) | 100-500 | 1000-3000 | US$30,000-100,000 | ~30% |
| 150L-600L | 100-500 kg | Production scale, commercial batches | 50-300 | 500-2000 | US$100,000-500,000 | ~50% |
| Above 600L | 500-2000+ kg | High-volume continuous, large pharma | 30-200 | 200-1000 | US$500,000-1,500,000+ | ~20% |
Key specifications: Bowl material (316L stainless steel, pharmaceutical grade). Jacketed (heating/cooling). Vacuum (solvent recovery). Spray nozzle (granulating liquid). Sealing (mechanical seal, magnetic drive). Control (PLC, HMI, SCADA, recipe management, data logging, 21 CFR Part 11 compliance for pharma). Cleaning (CIP, manual). Scale-up models.
Exclusive observation (Global Info Research analysis): The high-shear granulator market is dominated by European pharmaceutical equipment manufacturers (GEA (Germany), Glatt (Germany), Syntegon (Germany (formerly Bosch Packaging), IMA (Italy), L.B. Bohle (Germany), DIOSNA (Germany), Romaco (Germany)). Asian manufacturers (Yenchen (Taiwan), Tofflon (China), Shree Bhagwati, Prism, Falcon, Anchor Mark (India)) lower cost (30-50% less). Quality, validation, documentation differences. GEA, Glatt top tier.
User case – pharma tablet manufacturing (December 2025): Indian generic pharma manufacturer (Sun Pharma (not listed), Cipla, Dr. Reddy’s) installs high-shear granulator (GEA or Glatt, 400L) for wet granulation of metformin (diabetes drug) 500mg tablet. Batch size 250kg. Process: mixing API (active pharmaceutical ingredient) + excipients (lactose, PVP (Polyvinylpyrrolidone), starch, crospovidone). Spray water (purified). Granules dried (fluid bed dryer). Mill, blend with lubricant (magnesium stearate). Tablet compression.
User case – nutraceutical supplement (January 2026): US supplement manufacturer (GNC, Nature’s Bounty) uses high-shear granulator (L.B. Bohle, 150L) for Vitamin C effervescent granules. Granules direct packaged into sachets (Orange flavor). Capacity 50kg batch.
3. Technical Challenges
Batch-to-batch consistency – Impeller speed, chopper speed, granulation liquid addition rate, wet massing time, endpoint detection (power consumption, torque, temperature, conductivity). Critical process parameters (CPP).
Cleaning validation (pharma) – Cross-contamination risk (different products). Clean-in-place (CIP), manual cleaning, residue sampling (swab, rinse). Validation.
Technical difficulty – scale-up from lab to production: Lab scale (10L) to pilot (100L) to production (600L) requires impeller tip speed, fill volume, chopper speed geometric similarity. Scale-up factor 60x.
Technical development (October 2025): GEA Group introduced continuous high-shear granulation (ConsiGma) for continuous manufacturing (pharma). QbD (Quality by Design), PAT (Process Analytical Technology) (NIR (Near-Infrared), Raman). FDA continuous manufacturing support.
4. Competitive Landscape
Key players include: GEA Group (Germany – pharmaceutical & food), Syntegon (Germany – pharma), ACG (India – pharma capsules, granulation), Glatt Group (Germany – fluid bed, high-shear), L.B. Bohle (Germany – granulation), IMA Group (Italy – pharma machinery), Hosokawa Micron (Japan – powder processing), Yenchen Machinery (Taiwan), DIOSNA Dierks & Söhne (Germany), Freund (Japan), Romaco (Germany – (owned by Truking China)), Fluid Air (US), PerMix (US), Shree Bhagwati (India), Cronimo (India), Gansons (India), Chamunda Pharma Machinery (India), Prism (India), Falcon (India), Anchor Mark (India), Tofflon (China). European and Indian suppliers.
Regional dynamics: Europe (Germany, Italy) high end. India (many suppliers) low cost.
5. Outlook
High-shear granulation mixing equipment market will grow at 6.4% CAGR to US$570 million by 2032, driven by pharmaceutical OSD growth, generic drug manufacturing (India, China), and nutraceutical expansion. Technology trends: continuous granulation (vs batch), PAT (real-time monitoring), single-use (disposable) technologies (biopharma), and Industry 4.0 (data integration). Asia-Pacific growth (7-8% CAGR), Europe 5-6%.
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp
